NCT04915885

Brief Summary

High-quality contraceptive counseling can strengthen global efforts to reduce the unmet need for and suboptimal use of modern contraceptives. This study aims to identify a package of contraceptive counseling interventions designed to strengthen existing contraceptive services and determine its effectiveness in increasing clients' level of decision-making autonomy and meeting their contraceptive needs.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2022

Longer than P75 for not_applicable

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 24, 2021

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 7, 2021

Completed
7 months until next milestone

Study Start

First participant enrolled

January 1, 2022

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

May 17, 2024

Status Verified

May 1, 2024

Enrollment Period

2.9 years

First QC Date

May 24, 2021

Last Update Submit

May 16, 2024

Conditions

Keywords

CounselingEmpowermentAutonomy

Outcome Measures

Primary Outcomes (2)

  • Change in clients' decision-making autonomy

    Person-Centered Contraceptive Counseling scale (PCCC), developed and tested by Dehlendorf et al. (2021)

    Through study completion, an average of 1 year

  • Change in clients' met need for family planning

    number of participants who want to avoid a pregnancy and are using a contraceptive method / all participants

    Through study completion, an average of 1 year

Secondary Outcomes (1)

  • Change in modern contraceptive prevalence

    6 months and 12 months post enrollment

Study Arms (3)

Control arm

OTHER

routine contraceptive counseling and care and a range of family planning methods that are routinely available at field level

Other: Routine care

Intervention package

EXPERIMENTAL

contraceptive counseling package but still with a range of family planning methods that are routinely available at field level

Other: Package of contraceptive counseling interventions

Intervention package & expanded methods

EXPERIMENTAL

contraceptive counseling package but with an expanded range of family planning methods that are recommended by national guidance

Other: Package of contraceptive counseling interventionsOther: Expanded methods

Interventions

Routine contraceptive counseling and routine method availability

Control arm

The implementation package will be co-designed by providers and clients during the formative and research design phases

Intervention packageIntervention package & expanded methods

Expanded range of contraceptive methods as recommended by national policies

Intervention package & expanded methods

Eligibility Criteria

Age15 Years - 49 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
1. she comes to the family planning clinic with the intention to 1.a. use contraception for the first time in her life (new user), or 1.b. switch from a contraceptive method to another one (switching user), or 1.c. resume a method after not using any in the prior three months (lapse user), or 1.d. discontinue a modern method (discontinuing user); 2. she is not coming for the resupply of a currently used method, such as pills or injectables; 3. she has the intention to continue her follow-up at the health center during the 12-month study follow-up; 4. she does not participate in another study; and 5. she provides informed consent.

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

MeSH Terms

Conditions

Empowerment

Condition Hierarchy (Ancestors)

Social BehaviorBehavior
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
World Health Organization consultant

Study Record Dates

First Submitted

May 24, 2021

First Posted

June 7, 2021

Study Start

January 1, 2022

Primary Completion

December 1, 2024

Study Completion

December 1, 2025

Last Updated

May 17, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will share

(i) use of a controlled access approach, such as upon reasonable request from the World Health Organization; (ii) the trial will seek consent for sharing IPD from trial participants with adequate assurance that patient privacy and confidentiality will be maintained

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
Supporting information will become available 6 months after data collection and will be available for at least 3 years
Access Criteria
Upon reasonable request from the World Health Organization